Former Biogen exec wants new RTP startup to be an asset for Big Pharma By: Triangle Business Journal via Business Journals March 28, 2023 at 08:28 AM EDT A Triangle startup led by a former Biogen executive is raising capital to advance its lead drug into clinical trials. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
